Investment Thesis
Helsana HealthInvest AG invests in scalable start-ups with traction, targeting the Swiss market and broader DACH/Benelux/Nordics regions, excluding biotech, life sciences, and pharma.
Stage Focus
Series A to B
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Start-ups improving patient access to healthcare, fintech, insurtech, and cybersecurity
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€1,000,000 - €5,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (11)
B
Barbara Langsdorf
Investment Manager
B
Beat Riedle
Team Member
D
Dietrich Aumann
Investment Manager
D
Dr. Elisabeth Bourqui
Chair of the Board
D
Dr. Ralf Molitor
Managing Director
D
Dr. Ulrich Geilinger
Team Member
E
Elisabeth Bourqui
Investment Professional
R
Ralf Molitor
Managing Director
R
Roman Schuppisser
Board Member
U
Ulrich Geilinger
Investment Professional
Y
Yannick Bomhard
Investment Manager
